Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Abstract
A bstract: The epigenome is defined by DNA methylation patterns and the associated posttranslational modifications of histones. This histone code determines the expression status of individual genes dependent upon their localization on the chromatin. The silencing of gene expression is associated with deacetylated histones, which are often found to be associated with regions of DNA methylation as well as methylation at the lysine 4 residue of histone 3. In contrast, the activation of gene expression is associated with acetylated histones and methylation at the lysine 9 residue of histone 3. The histone deactylases play a major role in keeping the balance between the acetylated and deacetylated states of chromatin. Histone deacetylases (HDACs) are divided into three classes: class I HDACs (HDACs 1, 2, 3, and 8) are similar to the yeast RPD3 protein and localize to the nucleus; class II HDACs (HDACs 4, 5, 6, 7, 9, and 10) are homologous to the yeast HDA1 protein and are found in both the nucleus and cytoplasm; and class III HDACs form a structurally distinct class of NAD‐dependent enzymes that are similar to the yeast SIR2 proteins. Since inappropriate silencing of critical genes can result in one or both hits of tumor suppressor gene (TSG) inactivation in cancer, theoretically the reactivation of affected TSGs could have an enormous therapeutic value in preventing and treating cancer. Indeed, several HDAC inhibitors are currently being developed and tested for their potency in cancer chemotherapy. Importantly, these agents are also potentially applicable to chemoprevention if their toxicity can be minimized. Despite the toxic side effects and lack of specificity of some of the inhibitors, progress is being made. With the elucidation of the structures, functions and modes of action of HDACs, finding agents that may be targeted to specific HDACs and potentially reactivate expression of only a defined set of affected genes in cancer will be more attainable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Chromatin modification and epigenetic reprogramming in mammalian development
Li, E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg887 · Cited by 1,900
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
Ng, H.-H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., & Bird, A. (1999) · Nature Genetics · doi:10.1038/12659 · Cited by 936
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence
Langley, E. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2383 · Cited by 860
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Frye, R. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0897 · Cited by 807
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754
Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111871200 · Cited by 744
Ito, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723
Sir2 links chromatin silencing, metabolism, and aging
Guarente, L. (2000) · Genes & Development · doi:10.1101/gad.14.9.1021 · Cited by 716
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 694
(1996) · Europe PMC (PubMed Central) · Cited by 659
Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., & Dean, D. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80625-x · Cited by 658
The histone H4 acetyltransferase MOF uses a C 2 HC zinc finger for substrate recognition
Akhtar, A., & Becker, P. B. (2001) · EMBO reports · doi:10.1093/embo-reports/kve022 · Cited by 632
Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3
Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J., & Wong, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4342 · Cited by 629
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
Dunaief, J. L., Strober, B. E., Guha, S., Khavari, P. A., Ålin, K., Luban, J., Begemann, M., Crabtree, G. R., & Goff, S. P. (1994) · Cell · doi:10.1016/0092-8674(94)90405-7 · Cited by 624
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Brachmann, C. B., Sherman, J. M., Devine, S. E., Cameron, E. E., Pillus, L., & Boeke, J. D. (1995) · Genes & Development · doi:10.1101/gad.9.23.2888 · Cited by 605
Grozinger, C. M., & Schreiber, S. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140199597 · Cited by 588
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587
A histone deacetylase corepressor complex regulates the Notch signal transduction pathway
Kao, H.-Y., Ordentlich, P., Koyano-Nakagawa, N., Tang, Z., Downes, M., Kintner, C. R., Evans, R. M., & Kadesch, T. (1998) · Genes & Development · doi:10.1101/gad.12.15.2269 · Cited by 579
A Smad Transcriptional Corepressor
Wotton, D., Lo, R. S., Lee, S., & Massagué, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80712-6 · Cited by 561
HDAC4 deacetylase associates with and represses the MEF2 transcription factor
Miska, E. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5099 · Cited by 555
Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
The histone tails of the nucleosome
Luger, K., & Richmond, T. J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80134-2 · Cited by 521
Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., & Beppu, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41547-5 · Cited by 514
Butler, L. M., Zhou, X., Xu, W.-S., Scher, H. I., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182372299 · Cited by 510
CoREST is an integral component of the CoREST- human histone deacetylase complex
You, A., Tong, J. K., Grozinger, C. M., & Schreiber, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1454 · Cited by 502
FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor
Nakajima, H., Kim, Y. B., Terano, H., Yoshida, M., & Horinouchi, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4027 · Cited by 487
Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription
Fuks, F., Burgers, W. A., Godin, N., Kasai, M., & Kouzarides, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2536 · Cited by 473
Microarray Deacetylation Maps Determine Genome-Wide Functions for Yeast Histone Deacetylases
Robyr, D., Suka, Y., Xenarios, I., Kurdistani, S. K., Wang, A., Suka, N., & Grunstein, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00746-8 · Cited by 468
Vigushin, D. M., Ali, S., Pace, P., Mirsaidi, N., Ito, K., Adcock, I. M., & Coombes, R. C. (2001) · PubMed · Cited by 447
Yang, W.-M., Yao, Y.-L., Sun, J.-M., Davie, J. R., & Seto, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28001 · Cited by 438
Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation
Juan, L.-J., Shia, W.-J., Chen, M.-H., Yang, W.-M., Seto, E., Lin, Y.-S., & Wu, C.-W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000202200 · Cited by 419
Zhang, J., Kalkum, M., Chait, B. T., & Roeder, R. G. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00468-9 · Cited by 414
Münster, P. N., Troso-Sandoval, T. A., Rosen, N. X., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2001) · PubMed · Cited by 405
Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B. V., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205108 · Cited by 400
The histone deacetylase-3 complex contains nuclear receptor corepressors
Wen, Y.-D., Perissi, V., Staszewski, L. M., Yang, W.-M., Krones, A., Glass, C. K., Rosenfeld, M. G., & Seto, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7202 · Cited by 378
Sin Meets NuRD and Other Tails of Repression
Knoepfler, P. S., & Eisenman, R. N. (1999) · Cell · doi:10.1016/s0092-8674(00)81531-7 · Cited by 356
Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., & Lazar, M. A. (2000) · Genes & Development · doi:10.1101/gad.14.1.45 · Cited by 325
Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y., et al. (2000) · PubMed · Cited by 319
Self-citationHu, E., Chen, Z., Fredrickson, T., Zhu, Y., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Sung, C.-M., Liu, R., & Winkler, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908988199 · Cited by 309
He, L.-Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., Rifkind, R. A., Marks, P. A., Richon, V. M., & Pandolfi, P. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11537 · Cited by 303
RB and hbrm cooperate to repress the activation functions of E2F1
Trouche, D., Le Chalony, C., Muchardt, C., Yaniv, M., & Kouzarides, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11268 · Cited by 294
Characterization of a human RPD3 ortholog, HDAC3
Emiliani, S., Fischle, W., Van Lint, C., Al-Abed, Y., & Verdin, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2795 · Cited by 294
HDAC4, a Human Histone Deacetylase Related to Yeast HDA1, Is a Transcriptional Corepressor
Wang, A. H., Bertos, N. R., Vezmar, M., Pelletier, N., Crosato, M., Heng, H. H., Th’ng, J., Han, J., & Yang, X.-J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7816 · Cited by 294
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287
BRG-1 is required for RB-mediated cell cycle arrest
Strobeck, M. W., Knudsen, K. E., Fribourg, A. F., DeCristofaro, M. F., Weissman, B. E., Imbalzano, A. N., & Knudsen, E. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7748 · Cited by 258
Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10
Guardiola, A. R., & Yao, T.-P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109861200 · Cited by 253
Strober, B. E., Dunaief, J. L., Guha, S., & Goff, S. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1576 · Cited by 253
Jaboin, J. J., Wild, J., Hamidi, H., Khanna, C., Kim, C. J., Robey, R. W., Bates, S. E., & Thiele, C. J. (2002) · PubMed · Cited by 247
Cloning and characterization of a histone deacetylase, HDAC9
Zhou, X., Marks, P. A., Rifkind, R. A., & Richon, V. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191375098 · Cited by 245
SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities
David, G., Neptune, M. A., & DePinho, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203690200 · Cited by 236
Cell Cycle Arrest and Repression of Cyclin D1 Transcription by INI1/hSNF5
Zhang, Z.-K., Davies, K. P., Allen, J., Zhu, L., Pestell, R. G., Zagzag, D., & Kalpana, G. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5975-5988.2002 · Cited by 233
Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
Kim, Y. B., Lee, K.-H., Sugita, K., Yoshida, M., & Horinouchi, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202564 · Cited by 232
A New Family of Human Histone Deacetylases Related toSaccharomyces cerevisiae HDA1p
Fischle, W., Emiliani, S., Hendzel, M. J., Nagase, T., Nomura, N., Voelter, W., & Verdin, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11713 · Cited by 225
Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm
Verdel, A., Curtet, S., Brocard, M.-P., Rousseaux, S., Lemercier, C., Yoshida, M., & Khochbin, S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00542-x · Cited by 224
Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.835-848.2002 · Cited by 222
Zhang, C. L., McKinsey, T. A., Lu, J.-R., & Olson, E. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007364200 · Cited by 220
Histone deacetylase as a new target for cancer chemotherapy
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N., & Horinouchi, S. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100300 · Cited by 215
Inhibitors of Histone Deacetylase as New Anticancer Agents
Jung, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372058 · Cited by 213
Dnmt3L is a transcriptional repressor that recruits histone deacetylase
Deplus, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf509 · Cited by 210
mHDA1/HDAC5 Histone Deacetylase Interacts with and Represses MEF2A Transcriptional Activity
Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M.-P., & Khochbin, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908437199 · Cited by 204
Cloning and characterization of a novel human histone deacetylase, HDAC8
BUGGY, J. J., SIDERIS, M. L., MAK, P., LORIMER, D. D., MCINTOSH, B., & CLARK, J. M. (2000) · Biochemical Journal · doi:10.1042/bj3500199 · Cited by 197
ITAZAKI, H., NAGASHIMA, K., SUGITA, K., YOSHIDA, H., KAWAMURA, Y., YASUDA, Y., MATSUMOTO, K., ISHII, K., UOTANI, N., NAKAI, H., et al. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.1524 · Cited by 197
Regulation of histone deacetylase 2 by protein kinase CK2
Tsai, S.-C., & Seto, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204149200 · Cited by 196
Isolation and Characterization of Mammalian HDAC10, a Novel Histone Deacetylase
Kao, H.-Y., Lee, C.-H., Komarov, A., Han, C. C., & Evans, R. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108931200 · Cited by 193
Lai, A., Kennedy, B. K., Barbie, D. A., Bertos, N. R., Yang, X. J., Theberge, M.-C., Tsai, S.-C., Seto, E., Zhang, Y., Kuzmichev, A., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2918-2932.2001 · Cited by 185
Tong, J. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1114 · Cited by 181
Won, J., Yim, J., & Kim, T. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206064200 · Cited by 180
Methylation meets acetylation: Gene silencing
Bestor, T. H. (1998) · Nature · doi:10.1038/30613 · Cited by 179
Transcription therapy for cancer
Pandolfi, P. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204299 · Cited by 179
Acetylation of importin-α nuclear import factors by CBP/p300
Bannister, A. J., Miska, E. A., Görlich, D., & Kouzarides, T. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00445-0 · Cited by 176
Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis
Kwon, H. J., Kim, M. S., Kim, M. J., Nakajima, H., & Kim, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.1602 · Cited by 171
Lai, A., Lee, J. M., Yang, W.-M., DeCaprio, J. A., Kaelin, W. G., Seto, E., & Branton, P. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6632 · Cited by 168
Minucci, S., Nervi, C., Coco, F. L., & Pelicci, P. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204336 · Cited by 163
Galasinski, S. C., Resing, K. A., Goodrich, J. A., & Ahn, N. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201174200 · Cited by 157
Rice, J. C., & Allis, C. D. (2001) · Nature · doi:10.1038/35104721 · Cited by 153
Cloning and characterization of human histone deacetylase 8
Van den Wyngaert, I., de Vries, W., Kremer, A., Neefs, J.-M., Verhasselt, P., Luyten, W. H. M. L., & Kass, S. U. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01813-5 · Cited by 143
Herold, C., Ganslmayer, M., Ocker, M., Hermann, M., Geerts, A. E., Hahn, E. G., & Schuppan, D. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00257-4 · Cited by 143
Characterization of a human gene with sequence homology to Saccharomyces cerevisiae SIR2
Afshar, G., & Murnane, J. P. (1999) · Gene · doi:10.1016/s0378-1119(99)00162-6 · Cited by 135
Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Björkholm, M., Arsenian‐Henriksson, M., Gruber, A., et al. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5462 · Cited by 135
Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10
Fischer, D. D., Cai, R., Bhatia, U., Asselbergs, F. A. M., Song, C., Terry, R., Trogani, N., Widmer, R., Atadja, P., & Cohen, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108055200 · Cited by 133
The complexity of chromatin remodeling and its links to cancer
Neely, K., & Workman, J. L. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00067-7 · Cited by 133
Lee, B. I., Park, S. H., Kim, J. W., Sausville, E. A., Kim, H. T., Nakanishi, O., Trepel, J. B., & Kim, S. J. (2001) · PubMed · Cited by 131
Thiagalingam, S., Foy, R. L., Cheng, K., Lee, H. J., Thiagalingam, A., & Ponte, J. F. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00012 · Cited by 126
Self-citationDangond, F., Hafler, D. A., Tong, J. K., Randall, J., Kojima, R., Utku, N., & Gullans, S. R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8033 · Cited by 123
Zhou, X., Richon, V. M., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1056 · Cited by 120
Rashid, S. F., Moore, J. S., Walker, E. S., Driver, P. M., Engel, J., Edwards, C. E., Brown, G., Uskoković, M. R., & Campbell, M. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204269 · Cited by 119
Induction of γ-Globin by Histone Deacetylase Inhibitors
McCaffrey, P. G., Newsome, D. A., Fibach, E., Yoshida, M., & Su, M. S.-S. (1997) · Blood · doi:10.1182/blood.v90.5.2075 · Cited by 118
Mechanism of Cell Cycle Arrest Caused by Histone Deacetylase Inhibitors in Human Carcinoma Cells.
KIM, Y. B., KI, S. W., YOSNIDA, M., & HORINOUCHI, S. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.1191 · Cited by 117
Boeke, J., Ammerpohl, O., Kegel, S., Moehren, U., & Renkawitz, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005929200 · Cited by 115
Gruffat, H., Manet, E., & Sergeant, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf031 · Cited by 114
Histone deacetylase 3 associates with and represses the transcription factor GATA-2
Ozawa, Y., Towatari, M., Tsuzuki, S., Hayakawa, F., Maeda, T., Miyata, Y., Tanimoto, M., & Saito, H. (2001) · Blood · doi:10.1182/blood.v98.7.2116 · Cited by 113
Zhang, Y., & Dufau, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204417200 · Cited by 112
Cohen, L. A., Amin, S., Marks, P. A., Rifkind, R. A., Desai, D. H., & Richon, V. M. (1999) · PubMed · Cited by 112
Histone Deacetylases Augment Cytokine Induction of the iNOS Gene
Yu, Z., Zhang, W., & Kone, B. C. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000024253.59665.f1 · Cited by 111
Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities
Newmark, H. L., & Young, C. W. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590831 · Cited by 111
Milutinovic, S., Zhuang, Q., & Szyf, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202504200 · Cited by 104
Histone acetylation and the cell-cycle in cancer
Wang, C. (2001) · Frontiers in Bioscience · doi:10.2741/1wang1 · Cited by 103
Sodium butyrate induces P53‐independent, Fas‐mediated apoptosis in MCF‐7 human breast cancer cells
Chopin, V., Toillon, R., Jouy, N., & Bourhis, X. L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704456 · Cited by 103
Kitamura, K., Hoshi, S., Koike, M., Kiyoi, H., Saito, H., & Naoe, T. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01933.x · Cited by 98
Dangond, F., & Gullans, S. R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8891 · Cited by 96
Amin, H. M., Saeed, S., & Alkan, S. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03123.x · Cited by 93
Johnson, C. A., Padget, K., Austin, C. A., & Turner, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000824200 · Cited by 92
The Transcriptional Repressor Sp3 Is Associated with CK2-phosphorylated Histone Deacetylase 2
Sun, J.-M., Chen, H. Y., Moniwa, M., Litchfield, D. W., Seto, E., & Davie, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200378200 · Cited by 89
Chen, Z., Clark, S., Birkeland, M., Sung, C.-M., Lago, A., Liu, R., Kirkpatrick, R., Johanson, K., Winkler, J. D., & Hu, E. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00322-1 · Cited by 87
Sawa, H., Murakami, H., Ohshima, Y., Sugino, T., Nakajyo, T., Kisanuki, T., Tamura, Y., Satone, A., Ide, W., Hashimoto, I., et al. (2001) · Brain Tumor Pathology · doi:10.1007/bf02479423 · Cited by 84
Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype
Kim, M.-S., Son, M. W., Kim, W. B., Park, Y. I., & Moon, A. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00465-1 · Cited by 67
Demary, K. C., Wong, L., & Spanjaard, R. A. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00676-5 · Cited by 66
Côté, S., Rosenauer, A., Bianchini, A., Seiter, K., Vandewiele, J., Nervi, C., & Miller, W. H. (2002) · Blood · doi:10.1182/blood-2002-02-0614 · Cited by 62
Ransom, R. F., & Walton, J. D. (1997) · PLANT PHYSIOLOGY · doi:10.1104/pp.115.3.1021 · Cited by 62
Cohen, L. A., Marks, P. A., Rifkind, R. A., Amin, S., Desai, D. H., Pittman, B. P., & Richon, V. M. (2002) · PubMed · Cited by 56
Allfrey, V. G. (1966) · PubMed · Cited by 56
Human Histone Deacetylase 2,HDAC2(HumanRPD3), Is Localized to 6q21 by Radiation Hybrid Mapping
Betz, R. C., Gray, S. G., Ekström, C., Larsson, C., & Ekström, T. J. (1998) · Genomics · doi:10.1006/geno.1998.5435 · Cited by 19
Furukawa, Y., Kawakami, T., Sudo, K., Inazawa, J., Matsumine, A., Akiyama, T., & Nakamura, Y. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134323 · Cited by 15
Identification and Mapping of Human Histone Acetylation Modifier Gene Homologues
Randhawa, G. S., Bell, D. W., Testa, J. R., & Feinberg, A. P. (1998) · Genomics · doi:10.1006/geno.1998.5370 · Cited by 13
Inhibition of Polyomavirus ori- Dependent DNA Replication by mSin3B
Xie, A., & Folk, W. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.11809-11818.2002 · Cited by 4
(2001) · PubMed
Cited by
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
“The opposing activities of histone acetyltransferases (HATs) and histone deacetylases (HDACs) tightly regulate gene expression through chromatin modificatio”
BackgroundDas, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
Barnes, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706736 · Cited by 838
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Metadata
- Authors
- THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2003-03
- Volume
- 983
- Issue
- 1
- Pages
- 84-100
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1983094204
- Cited by
- 700
- References
- 138
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.